Johnson & Johnson (JNJ) Cash from Operations (2009 - 2026)
Johnson & Johnson recorded quarterly Cash from Operations of 2514000000.0 in Q1 2026, down 65.6% quarter-over-quarter from 7309000000.0 in Q4 2025, and down 39.77% year-over-year from 4174000000.0 in Q1 2025.
Johnson & Johnson's Cash from Operations history runs 18 years deep, the most recent figure standing at 2514000000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 39.77% year-over-year to 2514000000.0; the TTM figure through Mar 2026 stood at 22870000000.0 (down 7.72% YoY), while the FY2025 annual figure was 24530000000.0, up 1.09% from the prior year.
- Cash from Operations came in at 2514000000.0 for Q1 2026 at Johnson & Johnson, down from 7309000000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 9169000000.0 in Q3 2025 to a low of 2514000000.0 in Q1 2026.
- A 5-year average of 5439733333.33 and a median of 4182000000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations surged 123.63% in 2023 and sank 39.77% in 2026, its largest moves.
- Johnson & Johnson's Cash from Operations stood at 3979000000.0 in 2022, then jumped by 97.61% to 7863000000.0 in 2023, then slipped by 11.19% to 6983000000.0 in 2024, then increased by 4.67% to 7309000000.0 in 2025, then slumped by 65.6% to 2514000000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 2514000000.0, 7309000000.0, and 9169000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.33 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.51 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.83 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 3.92 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.19 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.54 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.62 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.10 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 2.51 Bn |
| Mar 29, 2026 | 2.51 Bn |
| Dec 28, 2025 | 7.31 Bn |
| Dec 28, 2025 | 7.31 Bn |
| Sep 28, 2025 | 9.17 Bn |
| Sep 28, 2025 | 9.17 Bn |
| Jun 29, 2025 | 3.88 Bn |
| Jun 29, 2025 | 3.88 Bn |
| Mar 30, 2025 | 4.17 Bn |
| Mar 30, 2025 | 4.17 Bn |
| Dec 29, 2024 | 6.98 Bn |
| Dec 29, 2024 | 6.98 Bn |
| Sep 29, 2024 | 7.99 Bn |
| Sep 29, 2024 | 7.99 Bn |
| Jun 30, 2024 | 5.63 Bn |
| Jun 30, 2024 | 5.63 Bn |
| Mar 31, 2024 | 3.66 Bn |
| Mar 31, 2024 | 3.66 Bn |
| Dec 31, 2023 | 7.86 Bn |
| Dec 31, 2023 | 7.86 Bn |
| Oct 1, 2023 | 7.49 Bn |
| Oct 1, 2023 | 7.49 Bn |
| Jul 2, 2023 | 4.18 Bn |
| Jul 2, 2023 | 4.18 Bn |
| Apr 2, 2023 | 3.26 Bn |
| Apr 2, 2023 | 3.26 Bn |
| Jan 1, 2023 | 3.52 Bn |
| Jan 1, 2023 | 3.52 Bn |
| Apr 3, 2022 | 3.98 Bn |
| Apr 3, 2022 | 3.98 Bn |
| Oct 3, 2021 | 8.29 Bn |
| Oct 3, 2021 | 8.29 Bn |
| Jul 4, 2021 | 5.31 Bn |
| Jul 4, 2021 | 5.31 Bn |
| Apr 4, 2021 | 4.07 Bn |
| Apr 4, 2021 | 4.07 Bn |
| Jan 3, 2021 | 8.34 Bn |
| Jan 3, 2021 | 8.34 Bn |
| Sep 27, 2020 | 8.38 Bn |
| Sep 27, 2020 | 8.38 Bn |
| Jun 28, 2020 | 3.45 Bn |
| Jun 28, 2020 | 3.45 Bn |
| Mar 29, 2020 | 3.36 Bn |
| Mar 29, 2020 | 3.36 Bn |
| Dec 29, 2019 | 6.40 Bn |
| Dec 29, 2019 | 6.40 Bn |
| Sep 29, 2019 | 7.53 Bn |
| Sep 29, 2019 | 7.53 Bn |
| Jun 30, 2019 | 5.95 Bn |
| Jun 30, 2019 | 5.95 Bn |
| Mar 31, 2019 | 3.54 Bn |
| Mar 31, 2019 | 3.54 Bn |
| Dec 30, 2018 | 6.24 Bn |
| Dec 30, 2018 | 6.24 Bn |
| Sep 30, 2018 | 6.27 Bn |
| Sep 30, 2018 | 6.27 Bn |
| Jul 1, 2018 | 6.08 Bn |
| Jul 1, 2018 | 6.08 Bn |
| Apr 1, 2018 | 3.61 Bn |
| Apr 1, 2018 | 3.61 Bn |
| Dec 31, 2017 | 6.11 Bn |
| Dec 31, 2017 | 6.11 Bn |
| Oct 1, 2017 | 6.27 Bn |
| Oct 1, 2017 | 6.27 Bn |
| Jul 2, 2017 | 5.77 Bn |
| Jul 2, 2017 | 5.77 Bn |
| Apr 2, 2017 | 2.91 Bn |
| Apr 2, 2017 | 2.91 Bn |
| Jan 1, 2017 | 4.28 Bn |
| Jan 1, 2017 | 4.28 Bn |
| Apr 3, 2016 | 2.19 Bn |
| Apr 3, 2016 | 2.19 Bn |
| Sep 27, 2015 | 6.14 Bn |
| Sep 27, 2015 | 6.14 Bn |
| Jun 28, 2015 | 5.47 Bn |
| Jun 28, 2015 | 5.47 Bn |
| Mar 29, 2015 | 2.87 Bn |
| Mar 29, 2015 | 2.87 Bn |
| Dec 28, 2014 | 4.60 Bn |
| Dec 28, 2014 | 4.60 Bn |
| Sep 28, 2014 | 4.65 Bn |
| Sep 28, 2014 | 4.65 Bn |
| Jun 29, 2014 | 5.53 Bn |
| Jun 29, 2014 | 5.53 Bn |
| Mar 30, 2014 | 3.92 Bn |
| Mar 30, 2014 | 3.92 Bn |
| Dec 29, 2013 | 4.14 Bn |
| Dec 29, 2013 | 4.14 Bn |
| Sep 29, 2013 | 5.95 Bn |
| Sep 29, 2013 | 5.95 Bn |
| Jun 30, 2013 | 5.05 Bn |
| Jun 30, 2013 | 5.05 Bn |
| Mar 31, 2013 | 2.28 Bn |
| Mar 31, 2013 | 2.28 Bn |
| Dec 30, 2012 | 3.38 Bn |
| Dec 30, 2012 | 3.38 Bn |
| Sep 30, 2012 | 4.98 Bn |
| Sep 30, 2012 | 4.98 Bn |
| Jul 1, 2012 | 4.25 Bn |
| Jul 1, 2012 | 4.25 Bn |
| Apr 1, 2012 | 2.80 Bn |
| Apr 1, 2012 | 2.80 Bn |
| Jan 1, 2012 | 1.74 Bn |
| Jan 1, 2012 | 1.74 Bn |
| Apr 3, 2011 | 2.32 Bn |
| Apr 3, 2011 | 2.32 Bn |
| Oct 3, 2010 | 5.03 Bn |
| Oct 3, 2010 | 5.03 Bn |
| Jul 4, 2010 | 3.84 Bn |
| Jul 4, 2010 | 3.84 Bn |
| Apr 4, 2010 | 3.69 Bn |
| Apr 4, 2010 | 3.69 Bn |
| Jan 3, 2010 | 5.29 Bn |
| Jan 3, 2010 | 5.29 Bn |
| Sep 27, 2009 | 5.09 Bn |
| Sep 27, 2009 | 5.09 Bn |
| Jun 28, 2009 | 3.36 Bn |
| Jun 28, 2009 | 3.36 Bn |
| Mar 29, 2009 | 2.83 Bn |
| Mar 29, 2009 | 2.83 Bn |